Preclinical development of the CDK4 selective inhibitor PF-07220060: Increased CDK4 versus CDK6 inhibition leads to improved anti-tumor efficacy at therapeutic concentrations

被引：0
|
作者：
Anders, Lars
Pascual, Bernadette
Boras, Britton
Cianfrogna, Julie
Garza, Scott
Li, Na
Yuan, Jing Tang
Moen, Mark
Huser, Nanni
Gallego, Gary
Jalaie, Mehran
Ninkovic, Sacha
Cho-Schultz, Sujin
Shen, Hong
Kath, John
Dress, Klaus
Diehl, Wade
Nair, Sajiv
Jones, Rhys
Lafontaine, Jennifer
Murtaza, Anwar
Sacaan, Aida
Chintharlapalli, Sudhakar
VanArsdale, Todd
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
595
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical development of CDK4/6 inhibitor for breast cancer
    Iwata, Hiroji
    BREAST CANCER, 2018, 25 (04) : 402 - 406
  • [42] Clinical development of CDK4/6 inhibitor for breast cancer
    Hiroji Iwata
    Breast Cancer, 2018, 25 : 402 - 406
  • [43] Palbociclib (Cyclin-Dependent Kinases CDK4 and CDK6 Selective Inhibitor) Induced Grade 3 Interstitial Pneumonitis
    Kunadharaju, R.
    Saradna, A.
    Ahmad, M.
    Fuhrer, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [44] DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathway
    Huimin Fan
    Wancheng Liu
    Yanqiong Zeng
    Ying Zhou
    Meiling Gao
    Liping Yang
    Hao Liu
    Yueyue Shi
    Lili Li
    Jiayuan Ma
    Jiayin Ruan
    Ruyun Cao
    Xiaoxia Jin
    Jian Chen
    Genhong Cheng
    Heng Yang
    Communications Biology, 6
  • [45] A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target
    Franceschini, Natasja
    Gaeta, Raffaele
    Krimpenfort, Paul
    Briaire-de Bruijn, Inge
    Kruisselbrink, Alwine B.
    Szuhai, Karoly
    Cleton-Jansen, Anne-Marie
    Bovee, Judith V. M. G.
    PalubeckaiteQ, Leva
    LABORATORY INVESTIGATION, 2022, 102 (04) : 391 - 400
  • [46] DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathway
    Fan, Huimin
    Liu, Wancheng
    Zeng, Yanqiong
    Zhou, Ying
    Gao, Meiling
    Yang, Liping
    Liu, Hao
    Shi, Yueyue
    Li, Lili
    Ma, Jiayuan
    Ruan, Jiayin
    Cao, Ruyun
    Jin, Xiaoxia
    Chen, Jian
    Cheng, Genhong
    Yang, Heng
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [47] Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer
    Fabin Dang
    Li Nie
    Jin Zhou
    Kouhei Shimizu
    Chen Chu
    Zhong Wu
    Anne Fassl
    Shizhong Ke
    Yuangao Wang
    Jinfang Zhang
    Tao Zhang
    Zhenbo Tu
    Hiroyuki Inuzuka
    Piotr Sicinski
    Adam J. Bass
    Wenyi Wei
    Nature Communications, 12
  • [48] Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer
    Dang, Fabin
    Nie, Li
    Zhou, Jin
    Shimizu, Kouhei
    Chu, Chen
    Wu, Zhong
    Fassl, Anne
    Ke, Shizhong
    Wang, Yuangao
    Zhang, Jinfang
    Zhang, Tao
    Tu, Zhenbo
    Inuzuka, Hiroyuki
    Sicinski, Piotr
    Bass, Adam J.
    Wei, Wenyi
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [49] Therapeutic targeting of CDK4/6 inhibitor resistant breast cancer
    Lim, Elgene
    Portman, Neil
    Alexandrou, Sarah
    Haupt, Susan
    Haupt, Ygal
    Caldon, Elizabeth
    CANCER RESEARCH, 2018, 78 (04)
  • [50] Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor
    Kobayashi, Makiko
    Takahashi-Suzuki, Ikuko
    Shimomura, Toshiyasu
    Iwasawa, Yoshikazu
    Hirai, Hiroshi
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 921 - 931
12345